MedTrace Logo

Child Growth and Development in East London

NCT05419336 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 558

Last updated 2025-05-20

No results posted yet for this study

Summary

The overarching objective of this research is to detect poor growth and delayed development early in childhood by developing an automated growth-screening algorithm. The screening algorithm will be created using cohort data and piloted for feasibility and acceptability in Tower Hamlets. The ultimate goals are to detect linear growth failure and delayed development early to identify two groups of children: first, children with serious underlying medical disorders, in whom earlier diagnosis and management would improve clinical outcomes; and second, children whose poor growth and/or delayed development is a manifestation of socioeconomic disadvantage, in whom targeted pre-school interventions may improve long term health and education outcomes.

Conditions

  • Stunted Growth
  • Stunting
  • Growth Disorders
  • Child Development

Sponsors & Collaborators

  • Barts & The London NHS Trust

    collaborator OTHER

  • Child Growth Foundation

    collaborator UNKNOWN

  • The Patients Association

    collaborator UNKNOWN

  • Queen Mary University of London

    lead OTHER

Principal Investigators

  • Prof Andrew Prendergast, DPhil MRCPCH · Queen Mary

Eligibility

Min Age
24 Months
Max Age
30 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-15
Primary Completion
2024-03-30
Completion
2024-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05419336 on ClinicalTrials.gov